Share on StockTwits

CombiMatrix (NASDAQ:CBMX) Director R Judd Jessup sold 13,679 shares of CombiMatrix stock in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $2.00, for a total value of $27,358.00. Following the sale, the director now directly owns 31,174 shares of the company’s stock, valued at approximately $62,348. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Separately, analysts at Zacks reiterated an “outperform” rating on shares of CombiMatrix in a research note on Friday, August 8th. They now have a $3.50 price target on the stock.

Shares of CombiMatrix (NASDAQ:CBMX) traded up 3.00% during mid-day trading on Thursday, hitting $2.06. 174,284 shares of the company’s stock traded hands. CombiMatrix has a 52 week low of $1.91 and a 52 week high of $4.44. The stock’s 50-day moving average is $2.20 and its 200-day moving average is $2.54. The company’s market cap is $22.8 million.

CombiMatrix Corporation is a molecular diagnostics company. The Company operates in the field of genetic analysis and molecular diagnostics through its wholly owned subsidiary, CombiMatrix Molecular Diagnostics, Inc located in Irvine, California.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.